Thyroid Autoimmunity and Autoimmunity in Chronic Spontaneous Urticaria Linked to Disease Severity, Therapeutic Response, and Time to Remission in Patients with Chronic Spontaneous Urticaria

Table 3

Information on demographics, diagnosis of and treatment for AITDs, and thyroid autoantibody results of patients with AITDs.

No.	Gender	Age at CSU onset (years)	Thyroid onset relative to CU and duration between thyroid diseases and CSU (months)	Diagnosis	Treatment	Anti-Tg; (+)	Anti-TPO; (+)
1	Female	17	Before, 108	Grave’s disease	Oral medication, unspecified	Yes	Yes
2	Female	47	Before, 24	Grave’s disease	Propylthiouracil	Yes	No
3	Female	62	Before, NA	Grave’s disease	S/P I-131, Levothyroxine	No	No
4	Female	55	Before, 60	Hashimoto’s disease	Levothyroxine	No	Yes
5	Female	41	Before, 21	Grave’s disease	Methimazole	Yes	Yes
6	Female	48	Before, NA	Subclinical hypothyroidism	NA	Yes	Yes
7	Female	48	Before, 84	Grave’s disease	Methimazole	No	Yes
8	Female	32	After, 24	Primary hypothyroidism	Levothyroxine	Yes	Yes
9	Female	31	After, 4.5	Grave’s disease	MMI	No	Yes
10	Female	53	After, 1	Subclinical hyperthyroidism	Methimazole	Yes	Yes
11	Female	24	After, 22	Grave’s disease	Methimazole	Yes	Yes
12	Female	17	After, 25	Hashimoto’s disease	Levothyroxine	Yes	Yes
13	Female	30	After, 24	Grave’s disease	Propylthiouracil	Yes	Yes
14	Female	12	After, 60	Unclassified	NA	Yes	Yes
15	Female	62	After, 1.5	Hashimoto’s disease	Observe	Yes	Yes
16	Female	41	After, 1.5	Grave’s disease	Methimazole	Yes	No
17	Female	46	After, 26	Grave’s disease	Methimazole	Yes	No
18	Female	54	After, 21	Hashimoto’s disease	Levothyroxine	Yes	Yes
19	Female	59	After, 2	Subclinical hypothyroidism	Levothyroxine	Yes	Yes

Abbreviations Used in Table 3. AITD: autoimmune thyroid disease, CSU: chronic spontaneous urticarial, and NA: no available data.